Protalix BioTherapeutics
PLX
#6195
Rank
$0.05 B
Marketcap
$1.10
Share price
0.00%
Change (1 day)
-26.67%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: $0.05 Billion

As of August 2022 Protalix BioTherapeutics has a market cap of $0.05 Billion. This makes Protalix BioTherapeutics the world's 6195th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$0.05 B36.63%
2021$0.03 B-68.69%
2020$0.12 B148.64%
2019$0.04 B5.47%
2018$0.04 B-50.05%
2017$0.09 B67.73%
2016$0.05 B-45.89%
2015$0.10 B-40.9%
2014$0.17 B-52.64%
2013$0.36 B-25.05%
2012$0.48 B14.95%
2011$0.42 B-47.68%
2010$0.80 B50.76%
2009$0.53 B283.05%
2008$0.13 B-45.77%
2007$0.25 B-75.03%
2006$1.03 B4063.51%
2005$0.02 B4150%
2004$0.58 M-50%
2003$1.16 M263.64%
2002$0.32 M-52.17%
2001$0.67 M

End of Day market cap according to different sources

On Aug 6th, 2022 the market cap of Protalix BioTherapeutics was reported to be:

$0.05 Billion
by Yahoo Finance
$0.05 Billion
by CompaniesMarketCap
$0.05 Billion
by Nasdaq
$0.05 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$276.44 B 533,898.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.94 B 19,107.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.41 B 6,498.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.87 B 22,832.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel